HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Klepetko, W. Articles by Wolner, E. Search for Related Content PubMed PubMed Citation Articles by Klepetko, W. Articles by Wolner, E.

The Annals of Thoracic Surgery, Vol 44, 303-309, Copyright © 1987 by The Society of Thoracic Surgeons

ARTICLES

Implantation of the Duromedics bileaflet cardiac valve prosthesis in 400 patients

W Klepetko, A Moritz, G Khunl-Brady, W Schreiner, W Schlick, J Mlczoch, G Kronik and E Wolner

From September, 1983, to April, 1986, 451 Duromedics bileaflet cardiac valve prostheses were implanted in 400 patients at our institution in Vienna. Aortic valve replacement was done in 190 patients, 157 underwent mitral valve replacement (1 patient also underwent tricuspid valve replacement), 52 underwent double valve replacement, and 1 patient underwent isolated reoperation for tricuspid valve replacement. Concomitant procedures were performed in 86 patients (21.5%). Sixty-one patients (15.2%) had undergone previous cardiac surgery; 32 (8%) had undergone earlier valve replacement. The early mortality rate (within 30 days) was 6.25% (25 patients). Follow-up was done on 337 surviving Austrian citizens; this represents 429 patient-years. The late mortality rate was 2.1% per patient-year (9 patients). We observed paravalvular leak in 3 patients (0.7% per patient-year), thromboembolism in 4 (0.9%), prosthetic valve endocarditis in 5 (1.2%), and anticoagulant-related hemorrhage in 10 (2.3%). Valve failure occurred in 8 patients (1.8%). We conclude, therefore, that good clinical results and a low complication rate can be achieved with this new type of valve.

This article has been cited by other articles:

				N. D. Desai and G. T. Christakis Bioprosthetic Aortic Valve Replacement: Stented Pericardial and Porcine Valves Card. Surg. Adult, January 1, 2008; 3(2008): 857 - 894. [Full Text]

				V. A. Ferraris and S. P. Ferraris Assessing the medical literature: let the buyer beware Ann. Thorac. Surg., July 1, 2003; 76(1): 4 - 11. [Abstract] [Full Text] [PDF]

				N. D. Desai and G. T. Christakis Stented Mechanical/Bioprosthetic Aortic Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 825 - 856. [Full Text]

				C. E.E. Kuntze, E. H. Blackstone, and T. Ebels Thromboembolism and mechanical heart valves: a randomized study revisited Ann. Thorac. Surg., July 1, 1998; 66(1): 101 - 107. [Abstract] [Full Text] [PDF]

				S. A. Blome-Eberwein, D. Mrowinski, J. Hofmeister, and R. Hetzer Impact of Mechanical Heart Valve Prosthesis Sound on Patients' Quality of Life Ann. Thorac. Surg., February 1, 1996; 61(2): 594 - 602. [Abstract] [Full Text]

				H. E. Scully and C. S. Armstrong Tricuspid valve replacement: Fifteen years of experience with mechanical prostheses and bioprostheses J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1035 - 1041. [Abstract] [Full Text]